We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Top Buys

Rank Stock Value
1
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$24M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$7.59M
3
CZR
Caesars Entertainment Corporation
CZR
+$5.85M
4
AVGO icon
Broadcom
AVGO
+$5.1M
5
ACIA
Acacia Communications Inc
ACIA
+$3.72M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.1M
2
WBC
WABCO HOLDINGS INC.
WBC
+$11.4M
3
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$11.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.3M
5
MU icon
Micron Technology
MU
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
901
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$113K 0.01%
+4,400
New +$89.1K
ATNX
902
DELISTED
Athenex, Inc. Common Stock
ATNX
$113K 0.01%
411
+46
+13% +$9.73K
TVTY
903
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$113K 0.01%
+9,979
New +$91.2K
HAL icon
904
CALL
Halliburton
HAL
$28.1B
$112K 0.01%
8,600
-66,600
-89% -$718K
LITS
905
Lite Strategy Inc
LITS
$29.7M
$112K 0.01%
+1,355
New +$82.2K
SH icon
906
ProShares Short S&P500
SH
$843M
$112K 0.01%
1,250
+689
+123% +$66.2K
CCK icon
907
CALL
Crown Holdings
CCK
$13B
$111K 0.01%
+1,700
New +$107K
FULC icon
908
Fulcrum Therapeutics
FULC
$287M
$111K 0.01%
+6,073
New +$95.6K
ARNA
909
DELISTED
Arena Pharmaceuticals Inc
ARNA
$111K 0.01%
+1,757
New +$96.7K
CGNX icon
910
Cognex
CGNX
$10.8B
$110K 0.01%
+1,842
New +$100K
RGLD icon
911
Royal Gold
RGLD
$19.8B
$110K 0.01%
884
-290
-25% -$35K
RIGL icon
912
Rigel Pharmaceuticals
RIGL
$769M
$110K 0.01%
+6,000
New +$108K
SEIC icon
913
SEI Investments
SEIC
$12.6B
$110K 0.01%
+2,008
New +$105K
WIX icon
914
WIX.com
WIX
$2.59B
$110K 0.01%
429
-7,459
-95% -$1.32M
DG icon
915
Dollar General
DG
$27.3B
$109K 0.01%
+571
New +$103K
GMED icon
916
Globus Medical
GMED
$11.6B
$109K 0.01%
+2,282
New +$110K
MPT
917
Medical Properties Trust
MPT
$2.45B
$109K 0.01%
5,823
-22,332
-79% -$395K
ON icon
918
ON Semiconductor
ON
$31.7B
$108K 0.01%
+5,448
New +$88.8K
PM icon
919
Philip Morris
PM
$290B
$108K 0.01%
+1,543
New +$113K
ROK icon
920
Rockwell Automation
ROK
$48.5B
$108K 0.01%
+508
New +$98.3K
WEX icon
921
WEX
WEX
$6.38B
$108K 0.01%
655
-251
-28% -$34.4K
ACGL icon
922
Arch Capital
ACGL
$33.4B
$107K 0.01%
3,737
+2,228
+148% +$61.6K
CHRS icon
923
Coherus Oncology
CHRS
$195M
$107K 0.01%
+6,000
New +$102K
JNUG icon
924
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$542M
$107K 0.01%
1,200
+1,160
+2,900% +$97.7K
KN icon
925
Knowles
KN
$3.32B
$107K 0.01%
6,992
+1,129
+19% +$16.8K
35 36
37
38 39

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.